Galectin Therapeutics GALT
NASDAQ GALT
$4.61 +0.26 (+5.98%)
At close: Sep 4, 2026 · 4:00 PM EDT

Galectin Therapeutics (GALT) Receivables - Other (2010 - 2011)

Galectin Therapeutics (GALT) posted quarterly Receivables - Other of -$234000.0 for Q1 2011.

Analysis

Galectin Therapeutics (GALT) Receivables - Other (2010 - 2011) Analysis & Trends

Galectin Therapeutics' Receivables - Other history runs 1 years deep, the most recent figure standing at -$234000.0 for Q1 2011.

  • In Q1 2011, Receivables - Other changed N/A year-over-year to -$234000.0; the TTM figure through Dec 2011 stood at -$234000.0 (changed N/A YoY), while the FY2011 annual figure was -$234000.0, down 200.0% from the prior year.
  • Receivables - Other for Q1 2011 stood at -$234000.0.
  • The five-year high for Receivables - Other was -$234000.0 in Q1 2011, with the low at -$234000.0 in Q1 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Galectin Therapeutics 304.34 Mn 304.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2011 -234,000.00
Dec 31, 2010 234,000.00